Inhalable Drug Delivery Devices Research Report - 2019 Medical Devices Pipeline Assessment - ResearchAndMarkets.com

DUBLIN--()--The "Inhalable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019" report has been added to ResearchAndMarkets.com's offering.

The Medical Devices sector report, "Inhalable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Inhalable Drug Delivery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Inhalable Drug Delivery Devices pipeline products.

Scope

  • Extensive coverage of the Inhalable Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Inhalable Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Inhalable Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Inhalable Drug Delivery Devices Overview

3 Products under Development

3.1 Inhalable Drug Delivery Devices - Pipeline Products by Stage of Development

3.2 Inhalable Drug Delivery Devices - Pipeline Products by Segment

3.3 Inhalable Drug Delivery Devices - Pipeline Products by Territory

3.4 Inhalable Drug Delivery Devices - Pipeline Products by Regulatory Path

3.5 Inhalable Drug Delivery Devices - Pipeline Products by Estimated Approval Date

3.6 Inhalable Drug Delivery Devices - Ongoing Clinical Trials

4 Inhalable Drug Delivery Devices - Pipeline Products under Development by Companies

4.1 Inhalable Drug Delivery Devices Companies - Pipeline Products by Stage of Development

4.2 Inhalable Drug Delivery Devices - Pipeline Products by Stage of Development

5 Inhalable Drug Delivery Companies and Product Overview

5.1 Acorda Therapeutics Inc Company Overview

5.2 Baxter International Inc Company Overview

5.3 Bellerophon Therapeutics Inc Company Overview

5.4 Breath Therapeutics Holding BV Company Overview

5.5 Canigma A.L LTD Company Overview

5.6 Edixomed Ltd Company Overview

5.7 iDTx Systems, Inc. Company Overview

5.8 Impel NeuroPharma Inc Company Overview

5.9 Kanabo Research Ltd Company Overview

5.10 Mallinckrodt Plc Company Overview

5.11 Medical Developments International Ltd Company Overview

5.12 Medspray BV Company Overview

5.13 NeuroproteXeon Inc Company Overview

5.14 Next Safety, Inc. Company Overview

5.15 Nobilis Therapeutics Inc Company Overview

5.16 Sandoz International GmbH Company Overview

5.17 Texas Tech University Health Sciences Center Company Overview

5.18 University of Texas Health Science Center at Houston Company Overview

5.19 Vectura Group Plc Company Overview

5.20 Vero Biotech LLC Company Overview

5.21 VitalMIST Company Overview

5.22 Windtree Therapeutics Inc Company Overview

6 Inhalable Drug Delivery Devices - Recent Developments

6.1 Apr 30, 2019: Windtree Therapeutics appoints Daniel Geffken to Board of Directors

6.2 Apr 26, 2019: AstraZeneca: Q1 2019 results

6.3 Apr 25, 2019: Baxter reports first-quarter 2019 results

6.4 Apr 23, 2019: Catalent invests $14 million at Its Eberbach, Germany Softgel facility

6.5 Apr 12, 2019: Inhalation Sciences wins place on prestigious EU-funded Life Science Investment Hotlist

6.6 Apr 11, 2019: Catalent Celebrates opening of second Shanghai facility to optimize global and local clinical supply solutions for China

6.7 Apr 05, 2019: JC Pharma plans stock exchange listing to develop CannatolRx

6.8 Apr 02, 2019: 3M Drug Delivery Systems relocates UK R&D to new, state-of-the-art facility

6.9 Apr 01, 2019: Inhalation Sciences receives new Contract Research order for DissolvIt

6.10 Apr 01, 2019: Vectura Group names Kevin Matthews to its board of directors

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/80gdr1

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices, Drug Delivery

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices, Drug Delivery